Our Division of Training, Workforce Development, and Diversity (TWD) supports programs at multiple career stages to foster the development of a strong and diverse biomedical research workforce. This post is the first in a series focused on data from NIGMS training programs and is similar to the ones we have done for our research project grant portfolio. Below, we examine trends in NIGMS applications and awards for the Individual Postdoctoral National Research Service Award (NRSA) (F32) and Pathway to Independence Award (K99) programs. NIGMS also supports institutional postdoctoral awards that include the Institutional Research and Academic Career Development Awards (IRACDA) (K12) and NRSA Institutional Postdoctoral Training Grants (T32) focused in clinical areas, and data on these programs were shared previously.
Continue reading “NIGMS Training Application and Funding Trends: Individual NRSA Postdoc and Pathway to Independence Awards”
NIGMS has made MIRA awards to Established Investigators (EI) and Early-Stage Investigators (ESI) for three full Fiscal Years (FY). In this Feedback Loop post, we provide an analysis of application, review, funding, and demographic trends for the MIRA program.
For the first two rounds of EI MIRAs, eligibility was limited to well-funded NIGMS investigators: PIs with two or more NIGMS R01-equivalent awards or one NIGMS R01-equivalent award for >$400,000 in direct costs. For the FY 2018 EI competition and beyond, eligibility was expanded to include any investigator with a single PD/PI NIGMS R01-equivalent that is up for renewal. For the FY 2016 ESI MIRA competition, ESIs and New Investigators (NI) at the assistant professor or equivalent level were eligible, whereas eligibility was restricted to ESIs in subsequent rounds. As always, a PI can apply for an extension of ESI status for various life and career events, including childbirth.
Continue reading “Application, Review, Funding, and Demographic Trends for Maximizing Investigators’ Research Awards (MIRA): FY 2016-2018”
NIGMS is committed to supporting a wide-ranging portfolio of biomedically relevant fundamental research. As we discussed in a previous Feedback Loop post, we see this approach as the best way to increase our understanding of life. For many years, one important dimension of diversity in our scientific portfolio—the organisms scientists use to conduct their research—was limited by technical considerations. However, recent advances such as the decreasing cost of genome sequencing and the development of the CRISPR system for genetic modification now make it possible to use an expanded range of research organisms.
Continue reading “Analysis of NIGMS Support of Research Organisms”